176 the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study Identifies Clinical Prognostic Markers and Establishes the Foundation for Large-Scale Translational Research in Cutaneous Lymphoma

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.252
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Secondary Cutaneous Diffuse Large B-Cell Lymphoma Has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-Cell Lymphoma, Leg Type

Acta Dermato-Venereologica
DermatologyMedicine
2016English

Prognostic Metabolic Markers in Cutaneous Melanoma

British Journal of Dermatology
DermatologyMedicine
2019English

Primary Cutaneous Anaplastic Large Cell Lymphoma

Journal of Cutaneous Pathology
DermatologyForensic MedicinePathologyHistology
2017English

Updates in Cutaneous Lymphoma: Evidence-Based Guidelines for the Management of Cutaneous Lymphoma 2018

British Journal of Dermatology
DermatologyMedicine
2019English

Validation of the CNS International Prognostic Index in a Large Asian Cohort-Data From the Singapore Lymphoma Study Group

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Prognostic Markers in Peripheral T-Cell Lymphoma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy